Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital of ChinaHKSE:03869 73 PB Ratio is 0.84 as of Sep. 01, 2026, which is 36% below its 10-year median of 1.31. GuruFocus rates HKSE:03869 with a GF Score™ of 73/100 and a GF Value™ of HK$5.53 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 615 Healthcare Providers & Services companies, Hospital of China ranks better than 84.23% on this metric.
Hospital Corporation of China Ltd stock PB Ratio (=0.84) is close to 10-year low of 0.84.
The historical rank and industry rank for Hospital of China's PB Ratio or its related term are showing as below:
HKSE:03869'
s PB Ratio Range Over the Past 10 Years
Min: 0.84 Med: 1.31 Max: 4.36
Current: 0.84
During the past 12 years, Hospital of China's highest PB Ratio was 4.36. The lowest was 0.84. And the median was 1.31.
HKSE:03869's PB Ratio is ranked better than 84.23% of 615
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs HKSE:03869: 0.84
During the past 12 months, Hospital of China's average Book Value Per Share Growth Rate was 53.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 25.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -17.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -14.90% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Hospital of China was 25.30% per year. The lowest was -44.30% per year. And the median was -10.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hospital of China PB Ratio Related Terms
Hospital of China PB Ratio Historical Data
* Premium members only.
The historical data trend for Hospital of China's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Hospital of China's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital of China PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital of China's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hospital of China's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hospital of China (HKSE:03869) has a PB Ratio of 0.84 as of Sep. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hospital of China and its competitors. This is 36% below median its historical median of 1.31. Over the past decade, Hospital of China's PB Ratio has ranged from 0.84 to 4.36. According to the industry distribution chart, Hospital of China ranks #97 out of 615 companies in the Healthcare Providers & Services industry, placing it in the top 15.8%.
Is Hospital of China's PB Ratio too high?
Hospital of China's current PB Ratio of 0.84 is 36% below median its 10-year median of 1.31. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 4.36. The Healthcare Providers & Services industry median PB Ratio is 1.98. Hospital of China's value of 0.84 is 57.6% below this industry median. Based on the distribution chart, Hospital of China ranks #97 out of 615 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Hospital of China has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hospital of China's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital of China ranks #97 out of 615 companies for PB Ratio. This places Hospital of China in the top 16% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.98. Hospital of China's value of 0.84 is 57.6% below this benchmark. Historically, Hospital of China's own PB Ratio has ranged from 0.84 to 4.36 over the past decade. While the company's 10-year median is 1.31 vs. the industry median of 1.98, Hospital of China has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 615 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital of China's current PB Ratio of 0.84 is 57.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hospital of China and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital of China's current PB Ratio is 0.84, which is 36% below median its own 10-year median of 1.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital of China stock overvalued right now?
Based on GuruFocus' analysis, Hospital of China (HKSE:03869) is currently considered Possible Value Trap. The stock's GF Value™ is HK$5.53, compared to a current price of HK$3.40 — trading 38.5% below its estimated fair value. The current PB Ratio is 0.84, which is 36% below median its 10-year median of 1.31 and 57.6% below the Healthcare Providers & Services industry median of 1.98. Hospital of China's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hospital of China (HKSE:03869), the current PB Ratio is 0.84 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital of China (HKSE:03869) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital of China stock appears to be undervalued.
The current stock price of HK$3.40 is trading 38.5% below its estimated GF Value™ of HK$5.53.
GuruFocus considers Hospital of China to be Possible Value Trap.
Key valuation signals for HKSE:03869:
PB Ratio: 0.84 (36% below median its 10-year median of 1.31)
GF Value™: HK$5.53 vs. price of HK$3.40 (38.5% below fair value)
Industry Position: 57.6% below the Healthcare Providers & Services median (#97 of 615)
No single metric tells the full story. See the HKSE:03869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Corporation of China Ltd is an investment holding company that operates and manages hospitals in the People's Republic of China. In addition to offering hospital management services, it also provides supply chain services, other ancillary services, and sells pharmaceutical products. The company has three operating segments, namely, Hospital management services, General hospital services, and the sale of pharmaceutical products. The General Hospital services segment is the primary revenue generator for the company. All the company's revenue is generates from PRC.
73GF Score
Get the complete analysis for HKSE:03869
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03869 has been successfully added to your 
